BMT ASX Week ended 07 Aug 2026

Weekly Investor Report

Beamtree Holdings Limited · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 0.12 AUD
-11.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -14.6% below the Trend Line and sits at 15.9% of its 52-week range. The latest completed week returned -11.1%, after a -7.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 22 out of 100
Latest Close 0.12 AUD 7 Aug 2026
1W Return -11.1% latest completed week
4W Return -7.7% short-term follow-through
12W Return 14.3% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 40.03% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -11.1% Latest completed week; four-week move -7.7%. Indicator stack 0/58 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.03% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 6 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -14.6% below the Trend Line and sits at 15.9% of its 52-week range. The latest completed week returned -11.1%, after a -7.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1412-week average 0.13

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.7% over four weeks, 14.3% over 12 weeks, and -52.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-11.1%
4W-7.7%
12W14.3%
26W-33.3%
52W-52.9%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.57Latest activity-pressure read.
Pressure change-29.8%Four-week change in activity pressure.
Leadership-33.63Latest relative-leadership reading.
RS change-17.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Jun 2025 Field coverage 67% Model confidence 34%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength72/100Blend of value, momentum, and quality. Underlying universe rank 29; rank 1 is best.
Value67/100Relative valuation strength. Underlying universe rank 34; rank 1 is best.
Quality65/100Profitability and accounting quality. Underlying universe rank 36; rank 1 is best.
Momentum66/100Medium-term price momentum. Underlying universe rank 35; rank 1 is best.
Growth67/100Revenue and earnings growth. Underlying universe rank 34; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-5.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
100.0%
Gross profit retained from each unit of revenue.
Operating margin
-21.8%
Operating profit retained from revenue.
Free-cash-flow margin
-6.5%
Free cash flow generated from revenue.
Return on invested capital
-11.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
0/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.2%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 6 relevant articles.

0 positive · 6 neutral · 0 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-59.3%Distance below the 52-week high.
13-week volatility16.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2616 weeks finished lower.
Best week+52.6%Week of 19 Jun.
Worst week-14.3%Week of 22 May.
Latest week-11.1%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains3
Flat weeks1
Modest losses6
Sharp losses10
Recent vol16.8%13-week weekly-return volatility.
Base vol11.1%52-week weekly-return volatility.
Up/down split16/31Count of positive and negative weeks in the 52-week window.
Average skew11.4% / -7.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape19/100

Trend, activity pressure, participation, and risk combine to a 19/100 tape read.

 Indicator analysis21/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.14; No reversal markers Next-Week ExpectancyNegative 40.03%

Next-week expectancy is negative with a 40.03% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors67/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 67; Small Cap Core rank 40 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment50/100

Weighted news tone is neutral across 6 relevant articles.

Beamtree Holdings Limited Announces Appointment of Gareth Pye as Chief Executive Officer, Effective 13 July 2026 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20260.12 AUD-11.1%0.14 AUD0.22 AUD0.57-33.63152.5KOff
31 Jul 20260.14 AUD-3.6%0.14 AUD0.22 AUD0.63-24.1494.5KOff
24 Jul 20260.14 AUD16.7%0.15 AUD0.22 AUD0.71-20.65456.2KOff
17 Jul 20260.12 AUD-7.7%0.15 AUD0.22 AUD0.76-33.07141.5KOff
10 Jul 20260.13 AUD-13.3%0.15 AUD0.22 AUD0.82-28.73649.6KOff
3 Jul 20260.15 AUD-3.2%0.15 AUD0.22 AUD0.24-19.375.0KOff
26 Jun 20260.15 AUD6.9%0.16 AUD0.22 AUD-0.38-16.9735.0KOff
19 Jun 20260.14 AUD52.6%0.16 AUD0.22 AUD-0.96-23.70336.6KOff
12 Jun 20260.10 AUD2.2%0.16 AUD0.22 AUD-1.50-50.57281.1KOff
5 Jun 20260.09 AUD-3.1%0.16 AUD0.22 AUD-1.49-51.69691.1KOff
29 May 20260.10 AUD6.7%0.17 AUD0.23 AUD-1.48-51.74112.0KOff
22 May 20260.09 AUD-14.3%0.17 AUD0.23 AUD-1.52-55.22783.2KOff
15 May 20260.10 AUD0.0%0.17 AUD0.23 AUD-1.43-48.59963.7KOff
8 May 20260.10 AUD-12.5%0.18 AUD0.23 AUD-1.35-50.122.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context